The Role of Hematopoietic Stem Cell Transplantation in Treating Blood Cancer – For Physician Associates

• This course closed on 03/23/2024.

Credit Available: ILNA, NCPD, NP, PA

• Enrollment in this course closed on 03/23/2024.

Activity Description

This webinar will focus on hematopoietic stem cell transplantation in treating blood cancer, including the goals and types of hematopoietic stem cell transplantation, the indications for stem cell transplant, the process from pre-transplant to cell infusion, side effect management and what to monitor for post-transplant and the short and long-term follow up requirements.

This course is available from:

June 14, 2023 until March 23, 2024

Course Instructors

Krishna Komanduri, MD LLS Professional Education Team

Physician-in-Chief, Helen Diller Family Comprehensive Cancer Center San Francisco, CA

Corinne Shamehdi, MPAS, PA-C LLS Professional Education Team

Inpatient Lead APP Tampa General Hospital Cancer Institute Tampa, FL

Target Audience

This CE activity is intended for oncology nurses, physician associates,  and other healthcare professionals involved in the care of patients with cancer.

Educational Objectives

After completing this CE activity, the participant should be better able to:

• • Describe the goals and types of hematopoietic cell transplantation used in the treatment of blood cancers, including autologous, allogeneic, and reduced-intensity allogeneic stem-cell transplantation
  • Describe the indications for hematopoietic stem cell transplant
  • Explain the process of pre-transplant evaluation, mobilization, cell collection, and cell infusion in patients with blood cancer
  • Explain the short and long-term follow up requirements
  • Identify resources for patient education and support

Accreditation, Support and Credit

Nursing Continuing Professional Development

Approval for nurses has been obtained by The Leukemia & Lymphoma Society National Office under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

 

Nurse Practitioner Continuing Education

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.00 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23056141. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Physician Associate Continuing Education

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 3/23/2023 to 3/23/2024 .
PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-206402.

ILNA Recertification Points

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas: Care Continuum (ONC, CBCN, CPHON, AOCNP), Care of the Pediatric Hematology and Oncology Patient (CPHON), Cellular Collection, Preparative Regimens, and Infusion (BMTCN), Disease Related Biology (CPHON), Early Post-Transplant Management and Education (BMTCN), Foundations of Transplant (BMTCN), Health Maintenance (CPHON), Late Post-Transplant Management and Education (BMTCN), Professional Practice/Performance (BMTCN, AOCNP), Psychosocial Dimensions of Care (AOCNP, CPHON, ONC, CBCN), Quality of Life (BMTCN), Transplant Process and Infusion (BMTCN), Treatment (OCN, CBCN, AOCNP, CPHON). 
Total points: 1.0*
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.

Support Statement

There is no commercial support associated with this CE activity.

Provider

This activity is provided by The Leukemia & Lymphoma Society, in collaboration with The AAPA African Heritage PA Caucus.

The African Heritage PA Caucus is an international unified vehicle of mentorship, giving rise to professional leaders charged with the continued empowerment of PHYSICIAN ASSOCIATES of African Heritage and the populations they serve.

Disclosure of Conflicts of Interest Policy

All persons who may impact the content of a CE activity, including faculty and planners, are required to fully disclose current and recent financial relationships with commercial interests. A conflict of interest may be considered to exist if such a person has financial relationships with the grantor or any non-eligible entities (commercial interests) that may have a direct impact on the content of the program. Financial relationship is defined as being a shareholder, consultant, grant recipient, research participant, employee, and/or recipient of other financial or material support. Recent is defined as within the past 24 months. The participants in this CE activity must be made aware of any such financial relationship(s). This disclosure policy is intended to protect all parties involved from any potential conflict of interest that may arise.

Faculty Disclosures

Krishna Komanduri, MD
Julius R. Krevans Distinguished Professor of Medicine
Chief, UCSF Health Division of Hematology/Oncology
Physician-in-Chief, Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA

Krishna Komanduri, MD:  Consultant for: Aegle Therapeutics, Avacta Life Sciences, Cargo Therapeutics, CRISPR, Incyte, Iovance, Genentech/Roche, Janssen, Novartis, OptumHealth

Corinne Shamehdi, MPAS, PA-C
Inpatient Lead APP
Hematology/Oncology
Tampa General Hospital Cancer Institute
Tampa, FL

Corinne Shamehdi, MPAS, PA-C:  has no financial relationships.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from The Leukemia & Lymphoma Society and The AAPA African Heritage PA Caucus do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated.

If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@mlieducation.org.

You must be enrolled to complete this activity for credit, however, you are not required to enroll simply to view the presentation.